Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Liposomes
Reexamination Certificate
2011-03-29
2011-03-29
Mullis, Jeffrey C (Department: 1796)
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Liposomes
C514S565000
Reexamination Certificate
active
07914814
ABSTRACT:
A preparation is disclosed for producing enhanced blood flow in tissue thus causing beneficial effects such as promoting hair growth on scalp tissue lacking sufficient hair, restoring normal sexual function in males with erectile dysfunction. Specifically, this is a preparation which provides local delivery of the amino acid L-arginine, an important biological precursor to the main substance which is responsible for relaxation of blood vessels permitting enhancement of blood flow. In the preferred embodiments, the L-arginine is provided so that it can be topically applied to the scalp or penis. The preparation also contains an agent which aids in the transfer of L-arginine into the tissue. In the preferred embodiments this agent overcomes the resistance to transfer caused by the high charge density of L-arginine. In the preferred embodiments this means is high ionic strength created by addition of choline chloride, magnesium chloride and sodium chloride. This preparation when applied nightly to scalp tissue lacking sufficient hair for a period of time causes substantial growth of hair on the scalp. Further, when applied to the penis of a subject with erectile dysfunction causes restoration of normal sexual function.
REFERENCES:
patent: 4681897 (1987-07-01), Brand
patent: 4702913 (1987-10-01), Marty
patent: 4732892 (1988-03-01), Sarpotdar et al.
patent: 4871839 (1989-10-01), Gibson
patent: 4950654 (1990-08-01), Horn
patent: 4976952 (1990-12-01), Lang et al.
patent: 5028435 (1991-07-01), Katz et al.
patent: 5180743 (1993-01-01), Watanabe et al.
patent: 5210099 (1993-05-01), Mody et al.
patent: 5254331 (1993-10-01), Mausner
patent: 5332758 (1994-07-01), Nakata et al.
patent: 5391550 (1995-02-01), Carniglia et al.
patent: 5405919 (1995-04-01), Keefer et al.
patent: 5428070 (1995-06-01), Cooke et al.
patent: 5439938 (1995-08-01), Snyder et al.
patent: 5476852 (1995-12-01), Cauwenbergh
patent: 5498420 (1996-03-01), Mentrup Edgar et al.
patent: 5505958 (1996-04-01), Bello et al.
patent: 5527797 (1996-06-01), Eisenberg et al.
patent: 5538740 (1996-07-01), Abad
patent: 5543430 (1996-08-01), Kaesemeyer
patent: 5576351 (1996-11-01), Yoshimura et al.
patent: 5595753 (1997-01-01), Hechtman
patent: 5629002 (1997-05-01), Weuffen et al.
patent: 5632981 (1997-05-01), Saavedra et al.
patent: 5648101 (1997-07-01), Tawashi
patent: 5691423 (1997-11-01), Smith et al.
patent: 5698738 (1997-12-01), Garfield et al.
patent: 5714472 (1998-02-01), Gray et al.
patent: 5762963 (1998-06-01), Byas-Smith
patent: 5789442 (1998-08-01), Garfield et al.
patent: 5807957 (1998-09-01), Samour et al.
patent: 5853768 (1998-12-01), Altadonna
patent: 5891459 (1999-04-01), Cooke et al.
patent: 5891472 (1999-04-01), Russell
patent: 5895658 (1999-04-01), Fossel
patent: 5906822 (1999-05-01), Samour et al.
patent: 5911980 (1999-06-01), Samour et al.
patent: 5922332 (1999-07-01), Fossel
patent: 5925372 (1999-07-01), Berner et al.
patent: 5939094 (1999-08-01), Durif
patent: 5976566 (1999-11-01), Samour et al.
patent: 6036977 (2000-03-01), Drizen
patent: 6103275 (2000-08-01), Seitz et al.
patent: 6117872 (2000-09-01), Maxwell et al.
patent: 6207713 (2001-03-01), Fossel
patent: 6242229 (2001-06-01), Pineau et al.
patent: 6287601 (2001-09-01), Russell
patent: 6375672 (2002-04-01), Aksan et al.
patent: 6387081 (2002-05-01), Cooper
patent: 6444234 (2002-09-01), Kirby et al.
patent: 6448267 (2002-09-01), Anggard et al.
patent: 6451337 (2002-09-01), Smith et al.
patent: 6458841 (2002-10-01), Fossel
patent: 6511991 (2003-01-01), Hrabie et al.
patent: 6538033 (2003-03-01), Bing
patent: 6558695 (2003-05-01), Luo et al.
patent: 6562370 (2003-05-01), Luo et al.
patent: 6565879 (2003-05-01), Luo et al.
patent: 6582724 (2003-06-01), Hsu et al.
patent: 6586000 (2003-07-01), Luo et al.
patent: 6602912 (2003-08-01), Hsu et al.
patent: 6617337 (2003-09-01), Wilcox
patent: 6716436 (2004-04-01), Seguin
patent: 6719997 (2004-04-01), Hsu et al.
patent: 6747063 (2004-06-01), Adams et al.
patent: 6787152 (2004-09-01), Kirby et al.
patent: 6835392 (2004-12-01), Hsu et al.
patent: 6858232 (2005-02-01), Verbiscar
patent: 7241456 (2007-07-01), Vromen
patent: 7267829 (2007-09-01), Kirby et al.
patent: 7442690 (2008-10-01), Prejean et al.
patent: 7629384 (2009-12-01), Fossel
patent: 2002/0015713 (2002-02-01), Murdock et al.
patent: 2002/0037854 (2002-03-01), Breton et al.
patent: 2002/0168325 (2002-11-01), Lerner
patent: 2002/0168424 (2002-11-01), Shahinpoor et al.
patent: 2007/0105763 (2007-05-01), Ghosh
patent: 2007/0253911 (2007-11-01), Tamarkin et al.
patent: 2337772 (2000-01-01), None
patent: 101 28 910 (2002-12-01), None
patent: 0338291 (1989-10-01), None
patent: 0391342 (1990-10-01), None
patent: 0 424 028 (1991-04-01), None
patent: 1210933 (2003-03-01), None
patent: 1 553 063 (1967-11-01), None
patent: 5940 (1968-04-01), None
patent: 2602678 (1988-02-01), None
patent: 2 740 453 (1997-04-01), None
patent: 2 810 540 (2001-12-01), None
patent: 2094142 (1982-09-01), None
patent: 04-005231 (1992-09-01), None
patent: 6-247832 (1994-09-01), None
patent: 7-53336 (1995-02-01), None
patent: 9/241156 (1997-09-01), None
patent: WO 88/06034 (1988-08-01), None
patent: WO 92/08705 (1992-05-01), None
patent: WO 94/09750 (1994-05-01), None
patent: WO 95/13060 (1995-05-01), None
patent: WO 95/15147 (1995-06-01), None
patent: WO 95/15147 (1995-06-01), None
patent: WO 96/08966 (1996-03-01), None
patent: WO9608966 (1996-03-01), None
patent: WO 96/14748 (1996-05-01), None
patent: WO 96/29988 (1996-10-01), None
patent: WO 97/10830 (1997-03-01), None
patent: WO 97/16983 (1997-05-01), None
patent: WO 97/39760 (1997-10-01), None
patent: WO 99/13717 (1999-03-01), None
patent: WO 00/40215 (2000-07-01), None
patent: WO 00/54773 (2000-09-01), None
patent: WO 00/69469 (2000-11-01), None
patent: WO 01/45713 (2001-06-01), None
patent: WO 2006/096360 (2006-09-01), None
Cooper et al. The Transdermal Delivery of Drugs, vol. II p. 57-62, 1986.
Birder, CAPLUS AN 1998:548084, 1998.
Hirvonen et al., “Effect of diffusion potential . . . ”,Journal of Controlled Release, 56, (1998),p. 33-39.
International Search Report for International Application Serial No. PCT/US05/05726 dated Sep. 9, 2005.
International Search Report for International Application Serial No. PCT/US05/13228 dated Jul. 5, 2005.
International Search Report for International Application Serial No. PCT/US05/13230 dated Oct. 28, 2005.
Pauly et al,Liposomes containing amino acids and peptides and proteins for skin care, Chemical Abstracts (1998), vol. 113, No. 65069.
Argiolas, A., et al., “Nitric Oxide is a Central Mediator of Penile Erection,”Neuropharmacology, vol. 11, pp. 1339-1344 (1994).
Bunker, C.D., “Alteration in scalp blood flow after the epicutaneous application of 3% minoxidil and 0.1% hexyl nicotinate in alopecia,”Correspondence, pp. 669.
DeBoer, E.M., “Does Topical Minoxidil Increase Skin Blood Flow? A Laser Doppler Flowmetry Study,”Acta Derm Venereo, vol. 68, pp. 271-274 (1988).
Dietz, N. M., “Is nitric oxide involved in cutaneous vasodilation during body heating in humans?”,J. Appl. Physiol., vol. 76, No. 5, pp. 2047-2053 (1994).
Garban, H., “Effect of aging on nitric oxide-mediated penile erection in rats,”Am. J. Physiol., vol. 268, pp. 467-475 (1995).
I-Sheng, T., “Evaluation of Vasulogenic Impotence Using Dynamic Penile Washout Test,”J. Formosan Med. Assoc., vol. 89, No. 11, pp. 992-996 (1990).
Kirkeby, H.J., “Role of the L-arginine
itric oxide pathway in relaxation of isolated human penile cavernous tissue and circumflex veins,”Acta Physiol Scand, vol. 149, pp. 385-392 (1993).
Klemp, P., “Subcutaneous Blood Flow in Early Male Patter Baldness,”J. Invest Dermatol, vol. 92, pp. 725-726 (1989).
Laan, E., et al., “Assessment of female sexual arousal: Response specificity and construct validity,”Psychophysiology, vol. 32, pp. 476-485 (1995).
Mathias, B. J. et al., “Topical Capsaicin for Chronic Neck Pain,”Am. J. Phys. Med. Rehabil., vol. 74, No. 1, pp. 39-44 (19
Mullis Jeffrey C
Strategic Science & Technologies, LLC
Wolf Greenfield & Sacks P.C.
LandOfFree
Topical delivery of arginine of cause beneficial effects does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Topical delivery of arginine of cause beneficial effects, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Topical delivery of arginine of cause beneficial effects will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2643660